Integrin alpha 2b/CD41 Antibody (745201) [PerCP]
Novus Biologicals, part of Bio-Techne | Catalog # FAB7616C
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Flow Cytometry
Label
PerCP (Excitation = 490 nm, Emission = 675 nm)
Antibody Source
Recombinant Monoclonal Mouse IgG1 Clone # 745201
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
heterodimer of human Integrin alpha 2B (Leu32-Arg993; R887L) Accession P08514 + human Integrin beta 3 (Gly27-Asp718) Accession P05106
Specificity
Detects human Integrin alpha2b/CD41 in direct ELISAs.
In direct ELISAs, no cross-reactivity
with recombinant human Integrin alpha5, alpha8, alphaV, beta3, beta5, beta6, recombinant mouse Integrin beta2b or beta3 is observed.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Applications for Integrin alpha 2b/CD41 Antibody (745201) [PerCP]
Application
Recommended Usage
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from hybridoma culture supernatant
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Integrin alpha 2b/CD41
Alternate Names
CD41, GP2B, GPIIb, GTA, HPA3, ITGA2b
Gene Symbol
ITGA2B
Additional Integrin alpha 2b/CD41 Products
Product Documents for Integrin alpha 2b/CD41 Antibody (745201) [PerCP]
Product Specific Notices for Integrin alpha 2b/CD41 Antibody (745201) [PerCP]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...